BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4268482)

  • 1. Isoelectric focusing of human plasminogen, plasmin, and derived heavy (A) and light (B) chains.
    Robbins KC; Summaria L
    Ann N Y Acad Sci; 1973 Jun; 209():397-404. PubMed ID: 4268482
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 3. The primary structure of human plasminogen. I. The NH 2 -terminal sequences of human plasminogen and the S-carboxymethyl heavy (A) and light (B) chain derivatives of plasmin.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1972 Nov; 247(21):6757-62. PubMed ID: 4263615
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation, characterization, and comparison of the S-carboxymethyl heavy (A) and light (B) chain derivatives of cat, dog, rabbit, and bovine plasmins.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1973 Sep; 248(18):6522-7. PubMed ID: 4269767
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.
    Boivin D; Provençal M; Gendron S; Ratel D; Demeule M; Gingras D; Béliveau R
    Arch Biochem Biophys; 2004 Nov; 431(2):197-206. PubMed ID: 15488468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
    Wiman B; Wallén P
    Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055
    [No Abstract]   [Full Text] [Related]  

  • 9. On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragments.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Sep; 57(2):387-94. PubMed ID: 126158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the NH 2 -terminal glutamic acid and NH 2 -terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robins KC
    J Biol Chem; 1973 May; 248(9):2984-91. PubMed ID: 4700448
    [No Abstract]   [Full Text] [Related]  

  • 11. The phylogeny of baboon fibrin-fibrinolysin.
    Hampton JW; McKee P
    Acta Zool Pathol Antverp; 1969 May; 48():59-62. PubMed ID: 4271524
    [No Abstract]   [Full Text] [Related]  

  • 12. Rabbit plasminogen and plasmin isozymes.
    Castellino FJ; Sodetz JM
    Methods Enzymol; 1976; 45():273-86. PubMed ID: 138065
    [No Abstract]   [Full Text] [Related]  

  • 13. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.
    Robbins KC; Summaria L; Hsieh B; Shah RJ
    J Biol Chem; 1967 May; 242(10):2333-42. PubMed ID: 4226004
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptidomic approach based on combined capillary isoelectric focusing and mass spectrometry for the characterization of the plasmin primary products from bovine and water buffalo beta-casein.
    Somma A; Ferranti P; Addeo F; Mauriello R; Chianese L
    J Chromatogr A; 2008 May; 1192(2):294-300. PubMed ID: 18400224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: On the primary structure of human plasminogen and plasmin, cyanogen bromide fragments.
    Wiman B; Wallén P
    Thromb Diath Haemorrh; 1975 Sep; 34(1):350. PubMed ID: 127402
    [No Abstract]   [Full Text] [Related]  

  • 16. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
    Kaplan AP; Austen KF
    J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chains.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Oct; 58(2):539-47. PubMed ID: 126863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immobilization of the human plasmin light chain and analysis of its complexes with streptokinase].
    Lezhen TI; Kudinov SA
    Ukr Biokhim Zh (1978); 1983; 55(3):302-6. PubMed ID: 6223427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinin system of human plasma. VI. The action of plasmin.
    Burrowes CE; Movat HZ; Soltay MJ
    Proc Soc Exp Biol Med; 1971 Dec; 138(3):959-66. PubMed ID: 4257083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.